Adeline Waltz|
Sam Burkert joined the MJ team as a risk transfer associate in the Risk Management + Commercial Insurance department. In his role, Sam collaborates with our clients and carrier partners to execute our clients’ insurance programs and risk management strategies. Sam plays an essential role in ensuring our clients have an exceptional experience while implementing the set strategy they decide.
Before working at MJ, Sam gained experience in the industry as a commercial client service specialist. Sam worked alongside his team to deliver consistent white glove client service on large commercial accounts, honing his strong expertise in construction. His attention to detail as he handles complex policies makes him an invaluable asset to the MJ team!
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
DeAnn DeckThe U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
DeAnn DeckThe No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More